UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): April 17, 2017
PetLife Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Nevada | 000-52445 | 33-1133537 | ||
(State or other jurisdiction | (Commission | (I.R.S. Employer | ||
of incorporation) | File Number) | Identification No.) |
38 West Main St., Hancock, MD | 21750 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (844) 473-8543
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Material Definitive Agreement.
On May 10, 2017, Dr. Geoff’s by PetLife, Inc. (“Dr. Geoff’s by PetLife”), a subsidiary of PetLife Pharmaceuticals, Inc. (“PetLife,” or the “Company”), entered into an asset purchase agreement and a supply agreement with Healthy Life Pets, LLC (“Healthy Life Pets”) to acquire certain assets, including the intellectual property of Healthy Life Pets’ product line, including the trademarked brand, “Dr. Geoff’s Real Pet Food,” and to purchase product for a period of time from Healthy Life Pets. The purchase price of the assets was 1,450,000 shares of common stock of the Company, 450,000 of which were issued at execution, with the remaining 1,000,000 shares of common stock vesting over two years. The supply agreement, when fulfilled, will require the issuance of 50,000 shares of common stock of the Company to Healthy Life Pets. All shares of Company common stock to be issued pursuant to these agreements are subject to restrictions on resale pursuant to a leak out agreement.
Dr. Geoff’s by PetLife projects a national rollout of the product line in the latter part of 2017. Also, Dr. Geoff’s by PetLife projects the inclusion of VitalZul™, the Company’s patent pending, non-toxic, bioactive formulation, into a second-generation line of pet food.
The foregoing descriptions of the asset purchase agreement, supply agreement, and leak out agreement are qualified in their entirety by the full text of the agreements, which are filed as Exhibits 10.1, 10.2 and 10.3 to, and incorporated by reference in, this report.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 17, 2017, as announced in a press release on the following day, Geoffrey Broderick resigned as President of the Company to focus on the Company’s pet food division, Dr. Geoff’s by PetLife, and the projected rollout of the Dr. Geoff’s product line through direct response marketing to consumers through infomercials and Internet promotions. Mr. Broderick has an extensive background in this industry; therefore, this move to the subsidiary is strategic to meet the Company’s goals.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On April 19, 2017, the Company organized in the State of Maryland a wholly-owned subsidiary, Dr. Geoff’s by PetLife, to operate the Company’s pet food division.
Item 9.01 Financial Statements and Exhibits.
The exhibits listed in the following Exhibit Index are filed as part of this report:
Exhibit No. |
Description | |
10.1 |
Asset Purchase Agreement between Healthy Life Pets, LLC and Dr. Geoff’s by PetLife, Inc. |
|
10.2 | Supply Agreement between Healthy Life Pets, LLC and Dr. Geoff’s by PetLife, Inc. | |
10.3 | Leak Out Agreement between Healthy Life Pets, LLC, Dr. Geoff’s by PetLife, Inc., and PetLife Pharmaceuticals, Inc. | |
99.1 | Press Release on April 18, 2017, “PetLife Finalizes Negotiations for Dr. Geoff’s Real Food for Pets” | |
99.2 | Press Release on May 23, 2017, “PetLife Closes Acquisition of Assets for Dr. Geoff’s Real Food for Pets” |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PETLIFE PHARMACEUTICALS, INC. | ||
(Registrant) | ||
Dated: May 25, 2017 | By: | /s/ Ralph T. Salvagno, MD |
Ralph T. Salvagno, MD | ||
Chief Executive Officer |
Asset Purchase Agreement
THIS ASSET PURCHASE AGREEMENT (this “ Agreement ”) is effective as of the 10 th day of May, 2017, by and between Healthy Life Pets, LLC (“ HLP ”), a Wyoming limited liability company, (the “ Seller ”), and Dr. Geoff’s by PetLife, Inc., a Maryland corporation (the “ Buyer ”), a wholly-owned subsidiary of PetLife Pharmaceuticals, Inc. (“ PTLF ”), a Nevada corporation.
R e c i t a l s
A. Seller owns various pet food products, including complementary products, under the brand “Dr. Geoff’s Real Food for Pets™” (the “ Business ”).
B. Subject to the terms and conditions of this Agreement, Seller is willing to sell to Buyer, and Buyer is willing to purchase from Seller, certain assets relating to the Business as set forth herein.
NOW, THEREFORE, in consideration of the foregoing, the benefits to be derived hereunder and the mutual promises contained herein, the parties hereby agree as follows:
A g r e e m e n t
Article I
Purchase and Sale of Assets and Certain Related Transactions
1.1 Purchase and Sale . At the Closing (as defined in Section 3.1 below), Seller will sell to Buyer, and Buyer will purchase from Seller, upon the terms and subject to the conditions set forth in this Agreement, all of the assets associated with and/or required to operate the Business, including, without limitation, the following assets:
(a) All of Seller’s rights in and to the trade name “Dr. Geoff’s Real Food For Pets” (the “ Trade Name ”); and
(b) All intangible assets associated with the Business, including books of business, proprietary rights, phone numbers, trade secrets, domain names, business records, customer relationships, contracts and goodwill (the “ Intangible Assets ”).
(c) See Exhibit A for a complete list of the assets being acquired, including the Trade Name, Intangible Assets and the tangible assets (hereinafter, collectively, as the “ Assets ”).
1.2 Seller’s Debts, Liabilities and Obligations . Except as specifically set forth on Exhibit B , the parties hereby acknowledge and agree that all debts, claims, obligations and liabilities whatsoever of Seller shall be the sole responsibility of Seller, and that Buyer is not assuming, and shall not be obligated or deemed to assume, any debt, claim or liability of Seller or any debt, claim or liability associated with the Business or the Assets for a period of 26 months.
1 |
ARTICLE II
PURCHASE PRICE
2.1 Purchase Price . Buyer shall pay to Seller for the Assets the amount of One Million Four Hundred Fifty Thousand (1,450,000) shares (the “ Purchase Price ”) of PTLF’s restricted common stock, listed under the symbol OTCQB: PTLF (the “ Common Stock ”), as follows:
(a) The initial payment of the Purchase Price shall be issued upon closing, with the deliverance of a stock certificate within ten (10) business days of the closing, in the amount of Four Hundred Fifty Thousand (450,000) shares the Common Stock (the “ Initial Payment ”);
(b) The secondary payment of the Purchase Price shall be One Million (1,000,000) shares of the Common Stock (the “ Secondary Payment ”). The Secondary Payment shall be issued in four (4) stock certificates, each for Two Hundred Fifty Thousand (250,000) shares of the Common Stock, which shall vest over a two (2) year period (the “ Vesting Stock ”), with Two Hundred Fifty Thousand (250,000) shares of the Common Stock vesting every six (6) months, on the following dates: November 1, 2017; May 1, 2018; November 1, 2018; and May 1, 2019 (the “ Vesting Period ”). The Buyer shall retain the four (4) stock certificates and send them to the Seller on or about the vesting date as stated herein.
(c) The shares of common stock issued as part of this Agreement shall be subject to a Leak Out Agreement, as entered into by the Parties, on May 1, 2017.
(d) The Common Stock issued to the Seller in the Initial Payment and the Secondary Payment, as is typical in the normal course of business of the Buyer, the Seller’s ownership in the Buyer, in regards to the Common Stock, may be diluted.
2.2 Closing Costs . Each party shall bear its own closing costs, including without limitation attorneys’ and accountants’ fees and costs, where applicable. Without limiting the generality of the foregoing, Seller shall be solely responsible for any brokerage fees or sales commissions incurred by Seller in connection with the transactions contemplated by this Agreement.
ARTICLE III
CLOSING
3.1 Closing Date . The closing of the transactions contemplated herein shall occur on May 1, 2017 (the “ Closing ”).
2 |
3.2 Closing Deliveries by Buyer to Seller . At the Closing, Buyer shall deliver, or cause to be delivered to Seller, the following, each in form and substance reasonably satisfactory to Seller:
(a) A certificate, executed by Buyer, dated as of the Closing, certifying that the conditions specified in Section 7.3 have been fulfilled; and
(b) The Initial Payment of the Purchase Price as specified in Section 2.1(a) shall be processed with the Buyer’s transfer agent for the timely issuance and receipt of the Initial Payment by the Seller.
3.3 Closing Deliveries by Seller to Buyer . At the Closing, Seller shall deliver, or cause to be delivered, to Buyer the following, each in form and substance reasonably satisfactory to Buyer:
(a) An Assignment and Bill of Sale, a copy of which is attached hereto as Exhibit C ;
(b) An Assignment of Intangible Assets, a copy of which is attached hereto as attached as Exhibit D ;
(c) Any other documentation reasonably required to fully vest title to the Assets in Buyer; and
(d) A certificate, executed by Seller, dated as of the Closing, certifying that the conditions specified in Section 7.2 have been fulfilled.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE SELLER
Seller hereby represents and warrants to Buyer that the following statements are correct and complete in all material respects as of the date hereof and as of Closing, which representations and warranties shall survive Closing:
4.1 Organization . Seller is a limited liability company, duly organized, validly existing and in good standing under the laws of the State of Wyoming.
4.2 Authorization . Seller has all necessary power and authority to execute and deliver this Agreement and the documents and agreements contemplated hereby, to consummate the transactions contemplated hereby and thereby, and to perform its obligations hereunder and thereunder. This Agreement has been duly and validly approved by all necessary action on the part of Seller, has been duly executed and delivered by Seller and constitutes a valid and binding obligation of Seller, enforceable against it in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to creditor’s rights generally or by equitable principles (whether considered in an action at law or in equity) and other customary limitations on enforceability.
3 |
4.3 Title to Assets . Seller has and will convey to Buyer good and marketable title to all the Assets, free and clear of any security interest, claim, lien or encumbrance.
4.4 Consents and Approvals . No consent, approval or authorization of, or declaration, filing or registration with any governmental or regulatory authority, or any other person or entity, is required to be made or obtained by Seller in connection with the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby.
4.5 Legal Proceedings . There are no claims, actions, suits or proceedings or arbitrations, either administrative or judicial, pending, or, to the knowledge of Seller, overtly threatened against or affecting the Business, Seller, or the Assets, or Seller’s ability to consummate the transactions contemplated herein, at law or in equity or otherwise, before or by any court or governmental agency or body, domestic or foreign, or before an arbitrator of any kind.
4.6 Taxes . Seller has, in respect of the Business, filed all tax returns that are required to be filed and has paid all taxes that have become due pursuant to such tax returns or pursuant to any assessment that has become payable or for which Buyer may otherwise have any transferee liability. All monies required to be withheld by Seller from employees of the Business for income taxes and social security and other payroll taxes have been collected or withheld, and either paid to the respective governmental bodies or set aside in accounts for such purpose.
4.7 Trademarks . Seller does not own any registered trademarks or “DBA” name in connection with the Business. The Seller has used various trademarks and, as used, has incorporated the “™” to indicate that certain words have been used by the Seller in its business and that they have not been registered. No royalty is payable to any person as a result of, or with respect to, the use of any trademarks, trade names or other intellectual property to the best of Seller’s knowledge. The operation of the Business as currently conducted does not infringe, misappropriate or conflict with any intellectual property right or other legally protectable right of another person. Seller has not received any notice of any claim by another person contesting the validity, enforceability, use or ownership of any of its trademarks or trade names.
4.8 Disclosure . There are no material facts relating to the Business or the Assets that have not been disclosed to Buyer, and Buyer has undertaken all reasonable due diligence.
4.9 No Untrue Statement . To the knowledge of Seller, none of the representations and warranties in this Article IV or made by Seller elsewhere in this Agreement contains any untrue statement of material fact or omits to state a material fact necessary, in light of the circumstances under which it was made, in order to make any such representation not misleading in any material respect.
4 |
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF BUYER
Buyer hereby represents and warrants to Seller that the following statements are correct and complete in all material respects as of the date hereof and as of Closing, which representations and warranties shall survive Closing:
5.1 Organization . Buyer is a corporation, duly organized, validly existing and in good standing under the laws of the State of Nevada.
5.2 Authorization . Buyer has all necessary company power and authority to execute and deliver this Agreement and the documents and agreements contemplated hereby, to consummate the transactions contemplated hereby and thereby, and to perform its obligations hereunder and thereunder. This Agreement has been duly and validly approved by all necessary company action on the part of Buyer, has been duly executed and delivered by Buyer and constitutes a valid and binding obligation of Buyer, enforceable against it in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to creditor’s rights generally or by equitable principles (whether considered in an action at law or in equity) and other customary limitations on enforceability.
5.3 Consents and Approvals . No consent, approval or authorization of, or declaration, filing or registration with any governmental or regulatory authority, or any other person or entity, is required to be made or obtained by Buyer in connection with the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby.
5.4 No Untrue Statement . To the knowledge of Buyer, none of the representations and warranties in this Article V or made by Buyer elsewhere in this Agreement contains any untrue statement of material fact or omits to state a material fact necessary, in light of the circumstances under which it was made, in order to make any such representation not misleading in any material respect.
ARTICLE VI
COVENANTS
6.1 Conduct of Business . Prior to the Closing, except as otherwise required by applicable law or as consented to in writing by the parties, Seller shall conduct the Business in the ordinary course of business. Prior to the Closing, Seller shall use all reasonable efforts to (1) preserve the possession and control of all of the Assets and the Business; (2) to preserve the good will of suppliers, customers, staff and employees of the Business and others having business relations with Seller; and (3) keep and preserve the Business as existing on the date of this Agreement.
5 |
6.2 Commercially Reasonable Efforts . Subject to the terms and conditions set forth in this Agreement, Seller and Buyer shall use commercially reasonable efforts (subject to, and in accordance with, applicable law) to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other parties hereto in doing, all things necessary, proper or advisable under applicable laws to consummate, and make effective, in the most expeditious manner practicable, the transactions contemplated by this Agreement, and no party hereto shall take or cause to be taken any action which would reasonably be expected to prevent, impede or delay the consummation of the transactions contemplated by this Agreement.
6.3 Further Assurances . Each party shall cooperate in good faith with the other and shall take all appropriate action and execute any documents, instruments, assignments, assumptions or conveyances of any kind which may reasonably be necessary or advisable to carry out any of the transactions contemplated hereunder, including without limitation any vehicle registrations. The parties shall cooperate in providing such information as may be necessary to be in compliance with relevant sections of the Internal Revenue Code.
6.4 Risk of Loss . Until Closing, all risk of loss or damage to the Assets shall be borne by Seller, and thereafter shall be borne by Buyer.
6.5 Delivery . Seller shall deliver possession of all Assets to Buyer at Closing.
6.6 Indemnification . Seller will not have any obligation to indemnify Buyer with respect to any loss until Buyer shall have suffered aggregate losses relating thereto in excess of $10,000, at which point Seller will be obligated to indemnify Buyer for the amount of such losses in excess of $10,000.
(a) Indemnification by Seller . Seller shall defend, indemnify and hold harmless Buyer and each of Buyer’s officers, directors, members, shareholders, employees, counsel, agents, and their respective successors and assigns (collectively, the “ Buyer Indemnitees ”) from and against, and shall reimburse the Buyer Indemnitees for, each and every any loss, damage, injury, harm, detriment, decline in value, liability, claim, demand, cost of any legal proceeding, settlement, judgment, award, fine, penalty, tax, fee, charge, cost or expense (including, without limitation, costs associated with avoiding any of the foregoing, and the fees, disbursements and expenses of attorneys, accountants and other professional advisors) (“ Loss ”) incurred by any Buyer Indemnitee, directly or indirectly, arising out of or in connection with: (i) any material inaccuracy in any representation or warranty of Seller hereunder; (ii) any material breach or nonfulfillment of any covenant, agreement or other obligation of Seller under this Agreement or any related documents; (iii) any liability or similar claim caused by the actions of the Seller arising from the business operations of the Business prior to Closing; or (iv) any debt, liability, or other obligation of Seller owing to the actions or responsibility of Seller arising (or relating to the period) prior to Closing of which Seller is provided notification, as outlined below, within 26 months of the Closing date.
6 |
(b) Indemnification by Buyer . Buyer shall defend, indemnify and hold harmless Seller and each of Seller’s officers, directors, shareholders, employees, counsel, agents, and their respective successors and assigns (collectively, the “ Seller Indemnitees ”) from and against, and shall reimburse the Seller Indemnitees for, each and every Loss incurred by any Seller Indemnitee, directly or indirectly, arising out of or in connection with: (i) any material inaccuracy in any representation or warranty of Buyer hereunder; (ii) any material breach or nonfulfillment of any covenant, agreement or other obligation of Buyer under this Agreement or any related documents; (iii) any liability or similar claim arising from the business operations of the Business after Closing.
(c) Indemnification Procedure . If any Proceeding shall be brought or asserted against a party entitled to indemnification (or any successor thereto) pursuant to Sections 6.7(a) or (b) (each, an “ Indemnitee ”) in respect of which indemnity may be sought under this Section 6.7 from an indemnifying party or any successor thereto (each, an “ Indemnitor ”), the Indemnitee shall give prompt written notice of such Proceeding to the Indemnitor. The Indemnitee shall, reasonably and in good faith, assist and cooperate in the defense thereof. Notwithstanding anything herein to the contrary, the Indemnitor shall not, without the Indemnitee’s prior written consent, settle or compromise any Proceeding or consent to the entry of judgment with respect thereto, but such consent shall not be unreasonably withheld.
ARTICLE VII
CONDITIONS
7.1 Conditions to Each Party’s Obligations under this Agreement . The respective obligations of each party to effect the transactions contemplated by this Agreement shall be subject to the fulfilment or waiver in writing by mutual agreement of the parties at or prior to Closing of the following conditions:
(a) None of the parties shall be subject to any decree, order or injunction of a United States federal or state court or foreign court of competent jurisdiction, which prohibits the consummation of the transactions contemplated by this Agreement, and no statute, rule or regulation shall have been enacted by any governmental authority which prohibits or makes unlawful the consummation of the transactions contemplated by this Agreement.
(b) No action, suit, investigation or proceeding before any governmental authority seeking to prevent or prohibit the consummation of the transactions contemplated by this Agreement shall be pending.
7.2 Conditions to Obligations of Seller under this Agreement . The obligation of Seller to effect the transactions contemplated by this Agreement shall be subject to the fulfilment or waiver in writing by Seller at or prior to the Closing of the following conditions:
(a) Buyer shall have performed in all material respects Buyer’s covenants and agreements contained in this Agreement required to be performed on or prior to the Closing.
7 |
(b) The representations and warranties of Buyer contained in this Agreement and in any document delivered in connection herewith shall be true and correct in all respects as of the Closing.
(c) Buyer shall have made or caused to be made all deliveries required by Section 3.2 of this Agreement.
(d) Buyer shall attest to its due diligence and confirm that it has had an adequate opportunity to review all documents material to this transaction.
7.3 Conditions to Obligations of Buyer under this Agreement . The obligation of Buyer to effect the transactions contemplated by this Agreement shall be subject to the fulfilment or waiver in writing by Buyer at or prior to the Closing of the following conditions:
(a) Seller shall have performed in all material respects its covenants and agreements contained in this Agreement required to be performed on or prior to the Closing.
(b) The representations and warranties of Seller contained in this Agreement and in any document delivered in connection herewith shall be true and correct in all respects as of the Closing.
(c) Since the date of this Agreement, there shall not have occurred and be continuing material adverse effect to the Assets or the Business within the Seller’s control.
(d) Seller shall have made all deliveries required by Section 3.3 of this Agreement.
(e) There must not have been made or threatened by any person any claim asserting that such person (a) is the holder or the beneficial owner of, or has the right to acquire or to obtain beneficial ownership of the Assets or (b) is entitled to all or any portion of the Purchase Price payable for the Assets.
(f) Buyer shall have obtained all necessary third-party and governmental consents, authorizations, licenses and/or permits to the sale of the Assets, including, without limitation, all appropriate licenses or permits as determined by Buyer in its sole discretion.
8 |
ARTICLE VIII
RESTRICTIVE COVENANTS
8.1 Non-Solicitation Covenants . Seller agrees and promises that, except with the express written consent of Buyer, the Seller, the Seller’s owner, or spouses or children will directly or indirectly, alone or in concert with others, for any or no reason, do or undertake any of the following activities at any time after the Closing for the maximum time as permitted by law:
(a) solicit, divert, accept business from or otherwise take away or interfere with any customers of the Business; or
(b) solicit, divert or induce any of Buyer’s employees to leave Buyer’s employment; or
(c) solicit, divert or induce any of Buyer’s contractors or outside consultants to terminate their contractual relationship with Buyer.
8.2 Non-Competition Covenants . Seller agrees and promises that, except with the express written consent of Buyer, the Seller, the Seller’s owner, or spouse or children will directly or indirectly, alone or in concert with others for any or no reason, do or undertake any of the following activities for five (5) years (or such lesser time as permitted by law) beginning effective as of Closing: operate or conduct a Competitive Business, whether as an owner, part-owner, affiliate, partner, agent, joint venturer, investor or in any other capacity. “ Competitive Business ” refers to any pet food business involving production of pet food or food products for companion animals, not including Cornucopia Pet Foods, Cornucopia Super-Food, Cornucopia Phyto-Food, or Cornucopia Crispy Treats, or those products under development that are not a result of the Intellectual Property of HLP and have been disclosed in general terms to the Company as of the execution of this document.
8.3 Reasonableness of Restrictions . Seller hereby represents and warrants to Buyer that it has carefully considered the provisions of this Article VIII and agree that the restrictions set forth, including without limitation the time period and definition of Competitive Business, are reasonable and restrict Seller’s and its affiliates’ rights to compete only to the extent necessary to protect the valid and legitimate business interests of Buyer. Seller further represents and warrants to Buyer that the Seller understands the legal and other consequences of entering into the promises and agreements contained in this Article VIII. If any restriction, including without limitation, any time restriction, contained in this Article VIII is deemed to be unenforceable by a court of competent jurisdiction, the parties hereto agree that such court may modify and enforce such restrictions to the extent it determines to be reasonable under the circumstances existing at that time.
8.4 Injunction . In the event of a breach or threatened breach by Seller of the provisions of this Article VIII, Buyer shall be entitled to an injunction restraining Seller as the case may be, from engaging in the competitive activities proscribed by this article. The Parties further agree that a violation of such provisions will cause immediate and irreparable damage to Buyer. Nothing contained in this Article VIII shall prohibit Buyer from also pursuing any other remedies available at law, and no action by Buyer in pursuing any other remedies shall constitute an election to forego other remedies.
9 |
8.5 Survival of Protections . The covenants and agreements contained in this Article VIII shall survive the termination or expiration of this Agreement.
ARTICLE IX
TERMINATION
9.1 Termination by Consent . This Agreement may be terminated at any time prior to the Closing by the written agreement of Seller and Buyer.
9.2 Termination by Seller or Buyer . At any time prior to Closing, this Agreement may be terminated by Seller or Buyer, if a United States federal or state court of competent jurisdiction or United States governmental authority shall have issued an order, decree or ruling or taken any other action (including the enactment of any statute, rule, regulation, decree or executive order) permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement (the “ Restraining Order ”) and such Restraining Order shall have become final and non-appealable; provided , however , that (i) the factual basis for the Restraining Order shall not be or relate to the breach of any representation, warranty, covenant or agreement set forth in this Agreement by the party seeking to terminate the Agreement under this Section and (ii) the party seeking to terminate this Agreement pursuant to this Section shall have complied in all material respects with Section 6.2 and shall have used its commercially reasonable efforts to remove such injunction, order or decree.
9.3 Termination by Seller . At any time prior to Closing, this Agreement may be terminated by Seller if (i) there has been a material breach by Buyer of any representation, warranty, covenant or agreement set forth in this Agreement or if any representation or warranty of Buyer shall have become untrue in any material respect, in either case such that the conditions set forth in Section 7.2 would not be satisfied and (ii) such breach is not curable, or, if curable, is not cured within thirty (30) days after written notice of such breach is given to Buyer by Seller; provided , however , that the right to terminate this Agreement pursuant to this Section shall not be available to Seller if Seller, at such time, is in material breach of any representation, warranty, covenant or agreement set forth in this Agreement such that the conditions set forth in Section 7.3 shall not be satisfied.
9.4 Termination by Buyer . At any time prior to Closing, this Agreement may be terminated by Buyer if (i) there has been a material breach by Seller of any representation, warranty, covenant or agreement set forth in this Agreement or if any representation or warranty of Seller shall have become untrue in any material respect, in either case such that the conditions set forth in Section 7.3 would not be satisfied and (ii) such breach is not curable, or, if curable, is not cured within thirty (30) days after written notice of such breach is given to Seller by Buyer; provided , however , that the right to terminate this Agreement pursuant to this Section shall not be available to Buyer if Buyer, at such time, is in material breach of any representation, warranty, covenant or agreement set forth in this Agreement such that the conditions set forth in Section 7.2 shall not be satisfied. Upon any termination by Buyer pursuant to this Section, Seller shall promptly refund the Deposit to Buyer.
10 |
ARTICLE X
MISCELLANEOUS
10.1 Tax and Information Returns . The parties shall reflect the allocations of the Purchase Price set forth in Section 2.3 in any and all applicable tax and information returns.
10.2 Confidentiality . Each Party shall use all information that it obtains from the others pursuant to this Agreement solely for the effectuation of the transactions contemplated by this Agreement or for other purposes consistent with the intent of this Agreement and shall not use any of such information for any other purpose, including, without limitation, the competitive detriment of the other Parties. Each Party may disclose such information to its/their respective affiliates, counsel, accountants, tax advisors and consultants as necessary to consummate this transaction. This provision shall not prohibit the use or disclosure of confidential information pursuant to court order or which has otherwise become publicly available through no fault of the recipient Party.
10.3 Notices . All notices, requests, consents and demands shall be given to or made upon the parties at their respective addresses set forth below, or at such other address as a party may designate in writing delivered to the other parties. Unless otherwise agreed in this Agreement, all notices, requests, consents and demands shall be given or made by personal delivery with signature required, by confirmed air courier, or by certified first class mail, return receipt requested, postage prepaid, to the party addressed as aforesaid. If sent by confirmed air courier, such notice shall be deemed to be given upon the earlier to occur of the date upon which it is actually received by the addressee as confirmed by the air courier (or if the date of such confirmed delivery is not a business day, the next succeeding business day). If mailed, such notice shall be deemed to be given upon the earlier to occur of the date upon which it is actually received by the addressee or the third business day following the date upon which it is deposited in a first-class postage-prepaid envelope in the United States mail addressed to such address.
If to Seller: | Healthy Life Pets, LLC |
668 North Coast Hwy., #414 | |
Laguna Beach, CA 92651 | |
And to: | ____________________ |
____________________ | |
____________________ | |
____________________ |
11 |
10.4 Assignment . Without the prior written consent of the other party, the benefits of this Agreement may not be assigned or in any other manner transferred and the obligations may not be delegated. Subject to the foregoing limitation on assignment and delegation, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective personal representatives, successors and assigns, and no other person shall have any right, benefit or obligation hereunder.
10.5 Choice of Law; Venue . This Agreement shall be construed in accordance with, and governed by, the substantive laws of, the State of Maryland, without reference to principles governing choice or conflicts of laws. Venue for any action hereunder shall lie exclusively in the courts of the State of Maryland and/or the United States District Court for the District of Maryland.
10.6 Severability . In the event any one or more of the provisions contained in this Agreement shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the validity of any other provision hereof and this Agreement shall be construed as if such invalid, illegal or unenforceable provision were not contained herein; provided that the Agreement as so modified preserves the basic intent of the parties.
10.7 Dispute Resolution . Any and all disputes arising in connection with this Agreement, whether the dispute arise from the terms and conditions of this Agreement or payment from one Party to another Party, for Products and/or Services, or any other reason, shall be resolved as set forth below.
a) Negotiation. Any dispute regarding this Agreement, or arising out of this Agreement, shall first be submitted by the complaining Party in writing (the “ Initial Notice ”) to the other Party for negotiation and resolution. The Parties shall attempt in good faith to resolve any dispute.
b) Mediation. In the event that any dispute is not resolved by negotiation within ninety (90) days from the date of the Initial Notice, the Parties agree to submit the dispute to mediation. The Parties further agree that their participation in mediation is a condition precedent to any Party commencing arbitration in relation to the dispute. Either Party to the dispute may give written notice to the other Party of his or her desire to commence mediation within ninety (90) days of the Initial Notice and the mediation must take place within thirty (30) days after the date that such notice of intention to mediate is given.
12 |
c) Any action, suit, or other legal proceeding which is commenced by a Party against the other Party, to resolve any matter arising under or relating to any provision of this Agreement shall be commenced only in the State of Maryland, USA, and each party consents to the jurisdiction and agrees that legal process may be served by United States certified mail, return receipt requested or Federal Express. Venue for any such action shall be in Baltimore, Maryland, USA. The arbitration to be instituted and held according to standard arbitration rules and will utilize The National Academy of Distinguished Neutrals (the “NADN”). The arbitration shall be decided by a panel of three (3) arbitrators selected in accordance with NADN. The applicable laws shall be those of the United States, specifically, the State of Maryland. The arbitration shall take place in the City of Baltimore, Maryland, where the arbitration award will be issued. The arbitrators shall be empowered to award only those damages which are permitted in this Agreement, subject to any disclaimers of damages and liability limits set forth in this Agreement, but the arbitrators shall not have the authority to reform, modify or materially change this Agreement. The arbitration award shall include costs of the arbitration, reasonable attorneys’ fees and reasonable costs for experts and other witnesses. The Parties agree that the arbitrators shall have the authority to issue measures necessary to protect either party’s name, proprietary information, trade secrets, know-how or any other proprietary right. The award of the arbitrators shall be final and binding upon the parties without appeal or review except as allowed by applicable United States federal law. In connection with any application to confirm, correct or vacate the arbitration award, any appeal of any order rendered pursuant to any such application, or any other action required to enforce the arbitration award, the prevailing party shall be entitled to recover its reasonable attorneys’ fees, disbursements and costs incurred in any post-arbitration award activities.
d) Agreement as Bar to Suit. The Parties stipulate that the provisions of this Agreement shall be a complete defense to any suit, action, or proceeding instituted in any federal, state, or local court or before any administrative tribunal with respect to any controversy or dispute related to this Agreement and which is arbitrable as set forth herein.
10.8 Captions . The captions used herein are for ease of reference only and shall not define or limit the provisions hereof.
10.9 Sale of Assets Only . This Agreement constitutes a sale of the Assets only and is not a sale of any interest in Seller. Buyer is not assuming and shall not be responsible for the payment of any liabilities or obligations of Seller whatsoever, except as expressly set forth herein.
13 |
10.10 Enforcement . In the event of a dispute between the parties arising under this Agreement, the party prevailing in such dispute shall be entitled to collect such party’s costs from the other party, including without limitation court costs and reasonable attorneys’ fees, whether such sums are expended with or without suit, at trial or on appeal.
10.11 Entire Agreement; Amendments . This Agreement and the exhibits attached hereto constitute the entire agreement between the parties hereto with respect to the subject matter contained herein, and there are no covenants, terms or conditions, express or implied, other than as set forth or referred to herein. This Agreement supersedes all prior agreements between the parties hereto relating to all or part of the subject matter herein. No representations, oral or written, modifying or contradicting the terms of this Agreement have been made by any party except as contained herein. This Agreement may not be amended, modified or canceled except as provided herein or by written agreement of the parties signed by the party against whom enforcement is sought.
10.12 Counterparts . Any number of counterparts of this Agreement may be signed and delivered and each shall be considered an original and together they shall constitute one agreement.
10.13 Survival . All of the covenants, representations and warranties contained in this Agreement shall survive the Closing and shall not be merged therein.
[signatures on following pages]
14 |
In Witness Whereof , the parties hereto have caused this Agreement to be executed as of the day and year first above written.
SELLER: | ||
HEALTHY LIFE PETS, LLC | ||
/s/ Tracy Wardak | ||
By: | Tracy Wardak | |
Its: | Manager | |
BUYER: | ||
DR. GEOFF’S BY PETLIFE, INC. | ||
/s/ Ralph Salvagno | ||
By: | Ralph Salvagno | |
Its: | Chief Executive Officer |
[additional signatures on next page]
15 |
CONSENT AND AGREEMENT
The undersigned, constituting all of the shareholders, directors, and officers of Healthy Life Pets, LLC, a Wyoming limited liability company hereby executes this Agreement for the sole purpose of acknowledging their consent to and agreement to be bound by the provisions of Article VIII of this Agreement, and to otherwise memorialize their consent to Healthy Life Pets, LLC entering into this Agreement.
/s/ Tracy Wardak | ||
Name: | Tracy Wardak | |
Title: | Manager |
16 |
EXHIBIT A
Assets
- | 20+ Hours of TV commercial video “Raw Footage,” produced by Sincbox Media, Inc. |
- | Professional-grade photographs and product/food photography |
- | Facebook & Instagram social media handles |
o | Instagram: DrGeoffs |
● | https://www.instagram.com/drgeoffs/ |
o | Facebook: DrGeoffs |
● | https://m.facebook.com/drgeoffs |
- | Dr. Geoff’s website including content, photos, videos, and entire developed site. |
- | Dr. Geoff’s Can Food Labels: All final design templates, layout and production run ready. |
- | Dr. Geoff’s Supplements Labels: All final design templates, layout and production run ready. |
- | Dr. Geoff’s Premium Brochure: All final design templates, layout and production run ready. |
- | Dr. Geoff’s Mini-Brochure: All final design templates, layout and production run ready. |
- | Dr. Geoff’s Business Cards: All final design templates, layout and production run ready. |
- | Dr. Geoff’s Case/Boxes for food: All final design templates, layout and production run ready. |
- | Dr. Geoff’s Corporate Power Point presentations. |
- | Art Work: Files of art work assets to be utilized in current & future marketing. |
- | Barcodes - All registered product barcodes and registration numbers. |
o | See bottom of this list |
- | Recipes and formulas for all food and complementary products (to be included at the end of this section) |
o | See bottom of this list |
- | Listing of all unregistered trademarks |
o | Dr. Geoff’s Real Food for Pets™ | |
o | Dr. Geoff’s Range Chicken™ | |
o | Dr. Geoff’s Wild Pacific Salmon™ | |
o | Dr. Geoff’s Farm Fresh Turkey™ | |
o | Antioxidant Power – Super Food™ | |
o | Immuno Boost – Phyto Food™ | |
o | Dr. Geoff’s On-The-Go Lid™ | |
o | Dr. Geoff’s On-The-Go Collapsible Bowl™ | |
o | A Loving Bite™ (A book authored by Dr. Geoffrey Broderick. The Buyer has the right to sell the book.) |
- | Multiple URL’s which have been purchased for current and future use as reflected below. |
- | Corporate Mailing Address of 668 North Coast Highway, #414, Laguna Beach, CA 92651 |
- | Contracts with all current vendors. They are all month to month. |
o | Moulton Logistics Management, 7850 Ruffner Ave., Van Nuys, CA 91406 | |
o | Moulton Logistics Management, 2440 Clements Ferry Rd., Charleston, SC 29492 |
Certain items are blacked out due to proprietary and confidential issues.
Owned Domains
(Hosted at Godaddy.com)
realfoodforpets.us | ||
trydrg.com | ||
realfoodforpets.info | ||
doctorgeoffsreviews.com | ||
realfoodforpets.org | ||
drgeoffsreviews.com | ||
doctorgeoff.com | ||
drgeoffs.com | ||
doctorgeoffs.com | ||
drgeoffspetfood.com | ||
doctorgeoffsrealfoodforpets.com | ||
drgeoffsrealfoodforpets.com | ||
drgeoffssuperfood.com |
HARVEST
% | INGREDIENT | |
21.5% | SALMON | |
16.1% | CHICKEN | |
16.1% | SARDINES | |
16.1% | CHICKEN LIVER | |
16.1% | TURKEY | |
10.48% | SALMON BROTH, CHICKEN BROTH, SARDINE BROTH, TURKEY BROTH | |
1.61% | TOMATOE PASTE | |
0.59% | WHOLE EGGS | |
0.53% | BREWERS YEAST | |
0.268% | SALT | |
0.268% | LOCUST BEAN GUM, GUAR GUM | |
0.008% | NATURAL VEGETABLE COLOR | |
0.0053% | CAT PREMIX VITAMIN | |
0.0053% | CAT PREMIX MINERAL | |
0.0026% | TAURINE | |
0.3328% | WATER |
TURKEY
% | INGREDIENT | |
18.8% | URKEY | |
18.8% | SARDINES | |
16.1% | CHICKEN LIVER | |
16.1% | SALMON | |
15.0% | BEEF LIVER | |
10.4% | TURKEY BROTH, SARDINE BROTH, SALMON BROTH | |
1.6% | TOMATO PASTE | |
1.0% | CARROTS | |
0.5% | WHOLE EGGS | |
0.26% | PEAS | |
0.26% | BREWERS YEAST | |
0.26% | SALT | |
0.26% | LOCUST BEAN GUM, GUAR GUM | |
0.008% | NATURAL VEGETABLE COLOR | |
0.0053% | CAT PREMIX VITAMIN | |
0.0053% | CAT PREMIX MINERAL | |
0.0026% | TAURINE | |
0.6388% | WATER |
CHICKEN
% | INGREDIENT | |
21.5% | CHICKEN | |
16.1% | CHICKEN LIVER | |
16.1% | SALMON | |
16.1% | BEEF LIVER | |
16.1% | SARDINES | |
10.48% | CHICKEN BROTH, SALMON BROTH, SARDINE BROTH | |
1.61% | TOMATO PASTE | |
0.59% | WHOLE EGG | |
0.53% | BREWERS YEAST | |
0.268% | SALT | |
0.268% | LOCUST BEAN GUM, GUAR GUM | |
0.008% | NATURAL VEGETABLE COLOR | |
0.0053% | CAT PREMIX VITAMIN | |
0.0053% | CAT PREMIX MINERAL | |
0.0026% | TAURINE | |
0.3328% | WATER |
NEW FORMULA
% | INGREDIENT | |
20.4% | SARDINES | |
20.4% | SALMON | |
15.3% | CHICKEN | |
15.3% | CHICKEN LIVER | |
15.3% | TURKEY | |
9.9% | SARDINE BROTH | |
1.5% | TOMATOE PASTE | |
0.56% | WHOLE EGGS | |
0.51% | BREWERS YEAST | |
0.255% | SALT | |
0.255% | LOCUST BEAN GUM, GUAR GUM | |
0.0076% | NATURAL VEGETABLE COLOR | |
0.0051% | CAT PREMIX VITAMIN | |
0.0051% | CAT PREMIX MINERAL | |
0.00255% | TAURINE | |
0.26965% | WATER |
THIS INFORMATION IS CONFIDENTIAL AND WILL BE
BLACKED OUT FOR PUBLIC FILING
EXHIBIT B
Assumed Debts, Liabilities and Obligations
None.
EXHIBIT C
Assignment & Bill of Sale
ASSIGNMENT AND BILL OF SALE
For good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Healthy Life Pets, LLC, a Wyoming limited liability company (“ Assignor ”), does hereby grant, bargain, transfer, sell, assign, convey and deliver to Dr. Geoff’s by PetLife, Inc., a Maryland corporation, or its assigns (“ Assignee ”), free and clear of any and all liens, encumbrances, charges or claims, as such terms are defined in the Asset Purchase Agreement between the parties of even date herewith. Assignor, for itself, its successors and assigns, hereby covenants and agrees that, at any time and from time to time forthwith upon the written request of Assignee, at no additional cost to Assignor, Assignor will do, execute, acknowledge and deliver or cause to be done, executed, acknowledged and delivered, each and all of such further acts, deeds, assignments, transfers, conveyances, powers of attorney and assurances as may reasonably be required by Assignee in order to assign, transfer, set over, convey, assure and confirm unto and vest in Assignee, its successors and assigns, title to the assets sold, conveyed, transferred and delivered by this Assignment and Bill of Sale.
This Assignment and Bill of Sale is being executed and delivered by Assignor pursuant to the terms of the Asset Purchase Agreement executed between the parties simultaneously herewith.
Executed effective as of the 10 th day of May, 2017.
ASSIGNOR: | ||
HEALTHY LIFE PETS, LLC | ||
/s/ Tracy Wardak | ||
By: | Tracy Wardak | |
Its: | Manager |
EXHIBIT D
Assignment of Tangible and Intangible Assets
ASSIGNMENT OF TANGIBLE AND INTANGIBLE ASSETS
This ASSIGNMENT OF TANGIBLE AND INTANGIBLE ASSETS (the “Assignment”) is made effective as of the 10 th day of May, 2017, by and between Healthy Life Pet, LLC, a Wyoming limited liability company, (“ Assignor ”), and Dr. Geoff’s by PetLife, Inc., a Maryland corporation (“ Assignee ”).
R E C I T A L S
A. Pursuant to the Asset Purchase Agreement (the “ Purchase Agreement ”) of even date herewith, by and among Assignor and Assignee, Assignor is assigning the Assets (as defined in the Purchase Agreement) to Assignee.
B. Included within the Assets being assigned to Assignee, and subject to the terms of the Purchase Agreement, Assignor is also assigning to Assignee all of its rights, title and interest in and to the tangible and intangible assets associated with the business of Assignor, including all books of business, proprietary rights, phone numbers, trade secrets, domain names, business records, customer relationships, contracts and goodwill and all of Assignor’s rights in and to the trade name “Dr. Geoff’s Real Food for Pets” (the “ Assets ”).
C. Pursuant to the terms of the Purchase Agreement, Assignor has agreed to transfer to Assignee all of the Assets, and Assignor now desires to enter into this Assignment in order to transfer such right, title and interest to Assignee.
NOW, THEREFORE, for and in consideration of the foregoing premises and the undertakings set forth below, Assignor hereby agrees as follows:
A G R E E M E N T
1. Assignor hereby grants, transfers, assigns and conveys to Assignee, absolutely and unconditionally, free and clear of all liens, encumbrances, mortgages or any other type of security interest, all of its right, title and interest in and to all of the Assets.
2. Assignor transfers such Assets to Assignee, its successors and assigns, to have and to hold to and for its and their own use and benefit forever. Assignor, for itself and its successors and assigns, hereby covenants that, from time to time after delivery of this instrument, at Assignee’s request and without further consideration, at no additional cost to Assignor, Assignor will execute and deliver, or will cause to be executed and delivered, such other instruments of conveyance and transfer and take such other actions as Assignee reasonably may require (such as, but not limited to, assisting with the transfer of any business accounts, such as a telephone account) to more effectively vest in the Assignee the Assets and to put Assignee in possession of the Assets, and to do all other things and execute and deliver all other instruments and documents as may be required to effect the same.
3. This Assignment shall be construed in accordance with, and governed by, the laws of the State of Maryland, without regard to its conflict of laws doctrine. Assignor consents and submits to the exclusive jurisdiction of the state courts located in Clark County, State of Maryland, for any disputes or controversies arising out of this Assignment.
IN WITNESS WHEREOF, Assignor has executed this Assignment effective as of the date first written above.
ASSIGNOR: | ||
HEALTHY LIFE PETS, LLC | ||
/s/ Tracy Wardak | ||
By: | Tracy Wardak | |
Its: | Manager |
SUPPLY AGREEMENT
This Supply Agreement (“Agreement”) is entered into on May 10, 2017 by and between Healthy Life Pets, LLC, a limited liability company organized and existing under the laws of Wyoming, having its registered office at 668 North Coast Hwy, #414, Laguna Beach, CA 92651 (“HLP,” hereinafter referred to as “Seller”); and Dr. Geoff’s by PetLife, Inc. (“DGPL,” hereinafter referred to as “Buyer”), a company organized and existing under the laws of Maryland, which is a wholly-owned subsidiary of PetLife Pharmaceutics, Inc., a company organized and existing under the laws of Nevada, having its registered office at 38 West Main Street, Hancock, MD 21750 (“PTLF”); also referred to hereinafter individually as “Party” and collectively as the “Parties.”
WHEREAS , Buyer wishes to acquire the supply of the products defined below on the terms and conditions identified herein;
WHEREAS , Seller wishes to supply and deliver such products to Buyer;
NOW THEREFORE , for good and valuable consideration, receipt and sufficiency of which is hereby acknowledged, Buyer and Seller agree as follows:
1. SUPPLY OF PRODUCTS
1.1 | During the term of this Agreement and any extension hereof, the Seller shall sell and supply the products as set out in Schedule 1 hereto (“Products”) to Buyer, and Buyer shall buy from the Seller such Products on an exclusive basis. |
1.2 | The maximum quantity of the Products are set out in Schedule 2 hereto. |
1.3 | Seller shall provide to Buyer the technical information and material in regard to the Products as set out in Schedule 3 hereto. |
1.4 | Seller shall provide to Buyer the third-party manufacturer of the Product (“Third-Party Manufacturer”) and arrange for a transition between the Seller and the Third-Party Manufacturer to the Buyer and the Third-Party Manufacturer. The Third-Party Manufacturer is identified in Schedule 4 hereto. |
2. ORDERS
2.1 | Each purchase and sale between Buyer and Seller shall be evidenced by an order placed by Buyer (“Order” or in plural “Orders”) to Seller in accordance with the terms and conditions of this Agreement and the Seller shall accept such Orders in writing within 2 working days after receipt of the Order. If the Seller does not send a written order confirmation within 2 working days after receipt of the Order, the Order shall be deemed to be accepted by the Seller. As long as this Agreement is in force and effect the terms and conditions of this Agreement shall apply to all Orders and all order confirmations of Seller. |
1 |
2.2 | Orders shall be placed by Buyer to Seller in writing (including, without limitation, by e-mail, fax, letter). Each Order shall contain |
(a) | the Products and the quantity of each Product ordered by Buyer, | |
(b) | the price, and | |
(c) | the destination (address) of delivery (“Destination of Delivery”). |
2.3 | Neither the Seller’s terms and conditions of sale and delivery nor the Buyer’s terms and conditions of purchase shall apply to any purchase and sale made under this Agreement. |
3. PRICE
3.1 | The price (“Price”) for the Products on the basis of DDP, Destination of Delivery as determined in the Order, as specified in Schedule 5 hereof. The Price includes statutory VAT and other taxes, if any. |
3.2 | The price remains fixed for the period of the contract. |
4. INVOICING AND PAYMENT
4.1 | Buyer shall pay to Seller the Price for the Products ordered as defined in Schedule 5. |
5. WAREHOUSED STOCK
5.1 | The inventory is at a third-party warehouse and is available for immediate delivery. |
6.
TITLE AND RISK
6.1 | Title and all risk of loss or damage to the Products shall pass from the Seller to Buyer when the Products shall be received and unloaded on the basis of DDP, Destination of Delivery as determined in the Order. |
7. WARRANTY AND PRODUCT LIABILITY
7.1 | The Seller warrant that the Products shall |
(a) | conform to the technical and quality standard and specifications as set out in Schedule 3 hereto, | |
(b) | be safe, of good quality and free from any defect in manufacturing or material, | |
(c) | correspond strictly with any and all representations, descriptions, advertisements, brochures, drawings, specifications and samples made or given by Seller, and | |
(d) | fit for the purpose of healthy food for companion pets. |
The Buyer shall have the right to inspect the received Products within 14 days after receipt of the delivery and shall inform the Seller within a further period of 3 working days of any apparent defect. Non-apparent defects shall be informed to the Seller within 14 days after they have become apparent.
2 |
7.2 | If the Products are defective and/or do not conform with the warranty given in Section 7.1 above (“Defective Products”), the Seller shall, at the option of the Buyer |
(a) | replace the Defective Products with Products in accordance with the warranty set out in Section 7.1 above as soon as possible without any additional cost to the Buyer, or | |
(b) | repair the Products without any additional cost to the Buyer, or | |
(c) | reimburse the Buyer the Price paid for the Defective Products. |
7.3 | Seller shall indemnify and hold the Buyer harmless from and against all claims, actions, damages, losses, liabilities (including, without limitation, product liability claims) and other expenses (including legal fees and costs) which the Buyer may suffer or incur as a result of the delivery of Defective Products or a breach of the obligations set out in this Agreement by Seller. |
7.4 | Any claim made under the breach of the warranty obligation as defined in Sections 7.1 and 7.2 above shall endure for a period of 24 months after the date of delivery of the Products and any claim made under Section 7.3 above shall endure until the expiration of the relevant statutes of limitations. |
8. MANAGEMENT REPORTING
8.1 | Seller shall report to the Buyer on a monthly basis the following management information: |
Inventory on hand |
9. TERM AND TERMINATION
9.1 | This Agreement shall come into force and effect on May 1, 2017 (“Effective Date”) and shall remain effective for a period of one (1) year. It shall remain in effect, unless |
(a) | this Agreement terminates in accordance with Section 9.2 below. | |
(b) | the Buyer begins to use the Third-Party Manufacturer after the initial inventory order is completed. |
9.2 | Notwithstanding Article 9.1 above this Agreement may be terminated at any time by each party on written notice with immediate effect in the event that: |
(a) | proceedings in bankruptcy or insolvency are instituted by or against the other party or a receiver, trustee, administrator or liquidator is appointed in respect of any part of the other party´s assets or any similar relief is granted under any applicable bankruptcy or equivalent law; | |
(b) | one party (the defaulting party) shall be in breach, non-observance or non-performance of any of its obligations in this Agreement and does not remedy the same within 14 days of notice of such failure or breach being served upon it by the other party (the non-defaulting party). |
10. FORCE MAJEURE
10.1 | In this Section “Force Majeure” shall mean any event beyond the reasonable control of the Buyer or Seller, and which is unavoidable, notwithstanding the reasonable care of the party affected, and shall include but not be limited to war, insurrection, riot, civil unrest, sabotage, boycott, embargo, explosion, fire, earthquake, flood, unavoidable accident, epidemic, act of God, action or inaction of any governmental official or agency (civil or military) and refusal of any licences or permits, if properly applied for. |
3 |
10.2 | If either Party is prevented from or delayed in performing any of its obligations under this Agreement by an event of Force Majeure, then it shall notify the other in writing of the occurrence of such event and the circumstances thereof within fourteen (14) days after the occurrence of such event. |
10.3 | The Party who has given such notice shall be excused from the performance or punctual performance of its obligations under this Agreement for so long as the relevant event of Force Majeure continues and to the extent that such Party’s performance is prevented or delayed. The occurrence of any event of Force Majeure affecting either party shall not give rise to any claim for damages or additional costs and expenses suffered or incurred by reason of Force Majeure. |
10.4 | If the performance of the work by Buyer is substantially prevented or is delayed for an aggregate period of more than sixty (60) days on account of one or more events of Force Majeure during the currency of this Agreement, the Buyer and/or Seller may terminate this Agreement by giving written notice to Seller and/or the Buyer as the case may be. |
11. NOTICES
All notices, requests, demands and other communications shall be in writing (including fax) in the English language and shall be addressed as follows (or to such other address as notified in writing by one party to the other party):
If to Buyer to:
Dr. Geoff’s by PetLife, Inc.
Attn: CEO
38 West Main Street
Hancock, MD 21750
With a copy to:
Lance Brunson, Esq.
Brunson Chandler & Jones PLLC
175 S. Main Street, Suite 1410
Salt Lake City, UR 84111
If to Seller to:
Healthy Life Pets, LLC
668 North Coast Hwy., #414
Laguna Beach, CA 92651
With a copy to:
_________________________
_________________________
_________________________
4 |
12. | MISCELLANEOUS |
12.1 | This Agreement shall be governed by and construed in accordance with the laws of the State of Maryland. |
12.2 | All disputes between the parties as to the validity, execution, performance, interpretation or termination of this Agreement will be submitted to the exclusive jurisdiction of the courts of Baltimore, Maryland. |
12.3 | All Schedules attached to this Agreement are incorporated herein and shall be part of this Agreement. |
12.4 | Except as otherwise specifically provided herein, neither party may assign this Agreement or any of its rights, interests or obligations hereunder without the prior written consent of the other party. |
IN WITNESS WHEREOF, Buyer and Seller have executed this Agreement on the dates below to be effective on the Effective Date.
BUYER | SELLER | |||
Dr. Geoff’s by PetLife, Inc. | Healthy Life Pets, LLC | |||
By: | /s/ Ralph Salvagno | By: | /s/ Tracy Wardak | |
Name: | Ralph Salvagno | Name: | Tracy Wardak | |
Title: | CEO | Title: | Manager | |
Date: | May 10, 2017 | Date: | May 10, 2017 |
5 |
SCHEDULE 1: LIST OF PRODUCTS
Description | Part No. | |
Dr. Geoff’s Range Chicken Wet Food Can | 10212 | |
Dr. Geoff’s Wild Pacific Salmon Wet Food Can | 10222 | |
Dr. Geoff’s Farm Fresh Turkey Wet Food Can | 10232 | |
Antioxidant Power – Super Food | 12402 | |
Immuno Boost Phyto Food Formula | 12412 | |
Lids | LID | |
On-the-go Collapsible Bowl | SILBOWL01 |
6 |
SCHEDULE 2: QUANTITY OF PRODUCTS
Description | Part No. | Qty. (a) | ||
Dr. Geoff’s Range Chicken Wet Food Can | 10212 | 317 | ||
Dr. Geoff’s Wild Pacific Salmon Wet Food Can | 10222 | 317 | ||
Dr. Geoff’s Farm Fresh Turkey Wet Food Can | 10232 | 317 | ||
Antioxidant Power – Super Food | 12402 | 228 | ||
Immuno Boost Phyto Food Formula | 12412 | 221 | ||
Lids | LID | 1,100 | ||
On-the-go Collapsible Bowl | SILBOWL01 | 1,100 |
THIS INFORMATION IS PROPREITARY AND CONFIDENTIAL AND IS
BLACKED OUT FOR PUBLIC FILING
7 |
SCHEDULE 3: TECHNICAL INFORMATION AND MATERIAL
HARVEST | ||
% | INGREDIENT | |
21.5% | SALMON | |
16.1% | CHICKEN | |
16.1% | SARDINES | |
16.1% | CHICKEN LIVER | |
16.1% | TURKEY | |
10.48% | SALMON BROTH, CHICKEN BROTH, SARDINE BROTH, TURKEY BROTH | |
1.61% | TOMATOE PASTE | |
0.59% | WHOLE EGGS | |
0.53% | BREWERS YEAST | |
0.268% | SALT | |
0.268% | LOCUST BEAN GUM, GUAR GUM | |
0.008% | NATURAL VEGETABLE COLOR | |
0.0053% | CAT PREMIX VITAMIN | |
0.0053% | CAT PREMIX MINERAL | |
0.0026% | TAURINE | |
0.3328% | WATER |
TURKEY | ||
% | INGREDIENT | |
18.8% | TURKEY | |
18.8% | SARDINES | |
16.1% | CHICKEN LIVER | |
16.1% | SALMON | |
15.0% | BEEF LIVER | |
10.4% | TURKEY BROTH, SARDINE BROTH, SALMON BROTH | |
1.6% | TOMATO PASTE | |
1.0% | CARROTS | |
0.5% | WHOLE EGGS | |
0.26% | PEAS | |
0.26% | BREWERS YEAST | |
0.26% | SALT | |
0.26% | LOCUST BEAN GUM, GUAR GUM | |
0.008% | NATURAL VEGETABLE COLOR | |
0.0053% | CAT PREMIX VITAMIN | |
0.0053% | CAT PREMIX MINERAL | |
0.0026% | TAURINE | |
0.6388% | WATER |
8 |
CHICKEN | ||
% | INGREDIENT | |
21.5% | CHICKEN | |
16.1% | CHICKEN LIVER | |
16.1% | SALMON | |
16.1% | BEEF LIVER | |
16.1% | SARDINES | |
10.48% | CHICKEN BROTH, SALMON BROTH, SARDINE BROTH | |
1.61% | TOMATO PASTE | |
0.59% | WHOLE EGG | |
0.53% | BREWERS YEAST | |
0.268% | SALT | |
0.268% | LOCUST BEAN GUM, GUAR GUM | |
0.008% | NATURAL VEGETABLE COLOR | |
0.0053% | CAT PREMIX VITAMIN | |
0.0053% | CAT PREMIX MINERAL | |
0.0026% | TAURINE | |
0.3328% | WATER |
NEW FORMULA | ||
% | INGREDIENT | |
20.4% | SARDINES | |
20.4% | SALMON | |
15.3% | CHICKEN | |
15.3% | CHICKEN LIVER | |
15.3% | TURKEY | |
9.9% | SARDINE BROTH | |
1.5% | TOMATOE PASTE | |
0.56% | WHOLE EGGS | |
0.51% | BREWERS YEAST | |
0.255% | SALT | |
0.255% | LOCUST BEAN GUM, GUAR GUM | |
0.0076% | NATURAL VEGETABLE COLOR | |
0.0051% | CAT PREMIX VITAMIN | |
0.0051% | CAT PREMIX MINERAL | |
0.00255% | TAURINE | |
0.26965% | WATER |
THIS INFORMATION IS PROPREITARY AND CONFIDENTIAL AND IS
BLACKED OUT FOR PUBLIC FILING
9 |
SCHEDULE 4: THIRD-PARTY MANUFACTURER
The Seller has set up the manufacturing of the products and accessories with the following:
Evanger’s Dog & Cat Food Co., Inc.
221 South Wheeling Road
Wheeling, IL 60090
847-537-0102
https://evangersdogfood.com/
THIS INFORMATION IS PROPREITARY AND CONFIDENTIAL AND IS
BLACKED OUT FOR PUBLIC FILING
10 |
SCHEDULE 5: PRICES
Description | Part No. | Qty. (b) | Unit Cost (a) | Total | ||||||||||||
Dr. Geoff’s Range Chicken Wet Food Can | 10212 | 317 cases | $ | 1.00 | $ | 3,804.00 | ||||||||||
Dr. Geoff’s Wild Pacific Salmon Wet Food Can | 10222 | 317 cases | $ | 1.00 | $ | 3,804.00 | ||||||||||
Dr. Geoff’s Farm Fresh Turkey Wet Food Can | 10232 | 317 cases | $ | 1.00 | $ | 3,804.00 | ||||||||||
Antioxidant Power – Super Food | 12402 | 228 | $ | 11.25 | $ | 2,565.00 | ||||||||||
Immuno Boost Phyto Food Formula | 12412 | 221 | $ | 11.25 | $ | 2,486.25 | ||||||||||
Lids | LID | 1,100 | $ | 0.23 | $ | 253.00 | ||||||||||
On-the-go Collapsible Bowl | SILBOWL01 | 1,100 | $ | 1.09 | $ | 1,199.00 | ||||||||||
Total | $ | 17,915.25 |
(a) Estimated
(b) Each case is 12 cans
50,000 shares of restricted common stock of PTLF, valued at $0.491 per share on the closing price on the date of the Letter of Intent, discounted to $0.358345 per share, or a discount of $6,634.75 shares of common stock, through a barter arrangement.
The 50,000 shares of common stock, after the Rule 144 restrictions have been removed, shall be subject to a Leak Out Agreement. The holder of the 50,000 shares of common stock agrees as part of this Agreement, to enter into a Leak Out Agreement which is a separate document to be entered into at Closing.
CERTAIN INFORMATION IS CONFIDENTIAL AND IS
BLACKED OUT FOR PUBLIC FILING
11 |
LEAK OUT AGREEMENT
This Leak Out Agreement (the “ Agreement ”) is made effective as of this 10th day of May 2017 by and between Dr. Geoff’s by PetLife, Inc. (“DGPL”), a Maryland corporation, and a wholly-owned subsidiary of PetLife Pharmaceuticals, Inc. (“PTLF”), a Nevada corporation (collectively, the “ Company ”), and Healthy Life Pets, LLC, a Wyoming limited liability company (the “HLP”).
R E C I T A L S
A. Pursuant to any and all shares of common stock of PTLF issued to HLP and/or its assignees, as a condition of the issuance of the shares of common stock, HLP agrees to a Leak Out Agreement. The purpose of the Agreement is to protect the Company from excessive stock selling of the common stock of PTLF as traded under the stock symbol PTLF.
B. Furthermore, HLP, should it become classified as an insider, is subject to the regulated times permissible for an insider to sell their common stock on the public market.
C. HLP will be issued up to 1,500,000 shares of common stock in exchange for inventory purchased, as contracted in a Supply Agreement between the DGPL and HLP, as dated May 10, 2017, and as contracted in an Asset Purchase Agreement between DGPL and HLP, as dated May 10, 2017 (collectively, the “Shares”).
D. This Agreement covers all past and to be issued securities of PTLF.
E. HLP is also bound by the various regulations of the Securities and Exchange Commission (the “SEC”), including, but not limited to, Rule 144.
F. PTLF and HLP desire and agree to place certain restrictions on the resale of the Shares.
A G R E E M E N T
NOW, THEREFORE, in consideration of the mutual covenants and representations set forth below, the Company and HLP agree as follows:
1. | Restriction on Resale of Shares. S ubject to the terms and conditions of this Agreement, the Company and HLP hereby agree that during the term of this Agreement, and until all of the Shares have been sold by HLP, HLP may sell no more than 2,000 shares of common stock into the market on any given trading day. Furthermore, HLP will sell shares into the market through the “ask” side of the market bid/ask and will not sell any shares on the “bid” side or “at market.” HLP recognizes the need to maintain the integrity of PTLF’s per share price in the market and agrees that selling “at market” or to the highest “bid” could cause a decrease in the highest price offered for shares of PTLF. Further, HLP shall provide a copy of this Agreement to its broker (the “Broker”) and the Broker shall be required to sign the acknowledgement attached hereto as Exhibit A acknowledging and agreeing to abide by the terms of this Agreement. |
1 |
2. | Private Transaction. If HLP desires to sell or transfer any of the Shares to another party in a private transaction, HLP must first obtain written approval from the Company, which approval may be withheld by the Company in its sole discretion for any or no reason. If the Company approves the sale or transfer by HLP, the recipient of the Shares will be required to strictly adhere to the same leak out restrictions as detailed above in Paragraph 1. Furthermore, prior to the sale or transfer of any of the Shares, the recipient must sign a binding agreement to such. |
3. | General Provisions . |
3.1. | Integration. This Agreement represents the entire agreement between the parties with respect to the subject matter hereof and supercedes and replaces any and all prior written or oral agreements regarding the subject matter of this Agreement including, but not limited to, any representations made during any interviews, relocation discussions or negotiations whether written or oral. | |
3.2. | Notices. Any notice, demand, offer, request or other communication required or permitted to be given by either the Company or HLP pursuant to the terms of this Agreement shall be in writing and shall be deemed effectively given the earlier of (i) when received, (ii) when delivered personally, (iii) one (1) business day after being delivered by facsimile (with receipt of appropriate confirmation), (iv) one (1) business day after being deposited with an overnight courier service or (v) four (4) days after being deposited in the U.S. mail, First Class with postage prepaid, and addressed to the parties at the addresses provided to the Company (which the Company agrees to disclose to the other parties upon request) or such other address as a party may request by notifying the other in writing. | |
3.3. | Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business or assets that executes and delivers the assumption agreement described in this Section or that becomes bound by the terms of this Agreement by operation of law. Subject to the restrictions on transfer set forth in this Agreement, this Agreement shall be binding upon HLP and his heirs, executors, administrators, successors and assigns. | |
3.4. | Waiver. Either party’s failure to enforce any provision of this Agreement shall not in any way be construed as a waiver of any such provision, nor prevent that party from thereafter enforcing any other provision of this Agreement. The rights granted both parties hereunder are cumulative and shall not constitute a waiver of either party’s right to assert any other legal remedy available to it. |
2 |
3.5. | Further Assurances . HLP agrees upon request to execute any further documents or instruments necessary or reasonably desirable in the view of the Company to carry out the purposes or intent of this Agreement. | |
3.6. | Severability. Should any provision of this Agreement be found to be illegal or unenforceable, the other provisions shall nevertheless remain effective and shall remain enforceable to the greatest extent permitted by law. | |
3.7. | Counterparts . This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the same agreement. Facsimile copies of signed signature pages shall be binding originals. | |
3.8. | Failure to Adhere: The Company or HLP who fails to fully adhere to the terms and conditions of this Agreement shall be liable to every other party for any damages suffered by any party by reason of any such breach of the terms and conditions hereof. HLP agrees that in the event of a breach of any of the terms and conditions of this Agreement by HLP, that in addition to all other remedies that may be available in law or in equity to the non-defaulting parties, a preliminary and permanent injunction, without bond or surety, and an order of a court requiring HLP to cease and desist from violating the terms and conditions of this Agreement and specifically requiring HLP to perform his/her/its obligations hereunder is fair and reasonable by reason of the inability of the parties to this Agreement to presently determine the type, extent or amount of damages that the Company may suffer as a result of any breach or continuation thereof. | |
3.9. | Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Maryland applicable to contracts entered into and to be performed wholly within said State; and the Company and HLP agree that any action based upon this Agreement may be brought in the United States and state courts of Maryland only, and submits himself/herself/itself to the jurisdiction of such courts for all purposes hereunder. | |
3.10. | Attorney Fees. In the event of default hereunder, the non-defaulting parties shall be entitled to recover reasonable attorney’s fees incurred in the enforcement of this Agreement. |
[Remainder of page intentionally left blank; signature page to follow.]
3 |
IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date first set forth above, and each party hereby represents that it/he has read this Agreement in its entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands this Agreement.
Dr. Geoff’s by PetLife, Inc. | ||
By: | /s/ Richard Salvagno | |
Ralph Salvagno, Chairman | ||
Healthy Life Pets, LLC | ||
By: | /s/ Tracy Wardak | |
Tracy Wardak, Manager |
2 |
Exhibit A
Acknowledgement to Leak Out Agreement dated as of May 10, 2017
between PetLife Pharmaceuticals, Inc.
and Healthy Life Pets, LLC
Date: ____________
Dear PetLife Pharmaceuticals, Inc.:
We act as the stock broker (the “Broker”) for Healthy Life Pets, LLC (“HLP”) regarding the sale of the common shares of PetLife Pharmaceuticals, Inc. (the “Company”). HLP has forwarded us a fully executed copy of the leak out agreement (the “Leak Out Agreement”) executed by HLP and the Company as of May 1, 2017. We hereby acknowledge the terms of the Leak Out Agreement and agree to abide by the terms of the Leak Out Agreement, specifically to sell no more than 2,000 shares of common stock per day and to not sell shares on the “bid” side of the bid/ask spread or “at market.”
Sincerely,
Broker Name:____________________________________
By: | ||
Its: |
3 |
FOR IMMEDIATE RELEASE
PetLife Finalizes Negotiations for Dr. Geoff’s Real Food for Pets
Product line of 25 supplements and pet accessories to roll out across the country
HANCOCK, MD—April 18, 2017— PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the “Company”), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, announced today that it has finalized the negotiations for the acquisition of Dr. Geoff’s Real Food for Pets™. The closing of the acquisition of the trademarked brands and the natural pet food product line is projected to occur within two weeks.
PetLife has expanded plans for a national rollout to the public by Summer 2017 with canned food and two Superfood Supplements, ImmunoPower™ and Antioxidant Boost™, which should have many benefits for companion pets. PetLife will, over time, roll out a complete product line of 25 foods, treats, supplements, and pet accessories. These include nutraceuticals, shampoos, creams, sprays, and other natural products (i.e. supplements) for dogs and cats.
“According to a March 2017 IBISWorld report, rising disposable income, coupled with the tendency for family members to treat pets like family members and an increase in wanting to feed their pets all-natural food, are expected to increase profits for all-natural pet product providers over the next five years,” said Ralph Salvagno, CEO of PetLife Pharmaceuticals. “Additionally, the number of pet-owning households is expected to grow from the current 65% of U.S. households that currently own a dog, increasing the potential consumer demand for Dr. Geoff’s Real Food for Pets ™ .”
Dr. Geoff’s Real Food for Pets™ already includes six SKUs of retail-ready products, including both canned food and antioxidant supplements. Since 1969, renowned veterinarian Dr. Geoffrey Broderick has been a pioneer in the premium, natural pet food industry.
Geoffrey Broderick, Jr., the son of Dr. Broderick, has resigned as President of the Company in order to focus on the development of the Company’s new subsidiary, Dr. Geoff’s by PetLife, Inc. He will bring his experience in the pet food industry and should be instrumental in the Company’s pet product subsidiary as our products go to market, where his focus will be on product distribution channels, the related marketing program, and manufacturing, in line with our anticipated growth.
About PetLife Pharmaceuticals, Inc.
PetLife Pharmaceuticals, Inc. (PTLF) ( www.PetLifePharma.com ) is a registered U.S. Veterinary Pharmaceutical company. PetLife’s mission is to bring its new, scientifically-proven, non-toxic, potentiated bioactive nutraceuticals and prescription medication, VitalZul™, to the world of veterinary oncology with the ultimate goal of preventing cancer and extending the life of pets suffering from cancer while improving their quality of life. In the U.S. alone, consumer spending on domestic companion animals reached over $60 billion in 2015 with over $29 billion spent on veterinary care and medications.
Forward looking statement:
This press release contains certain “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. The economic, competitive, governmental, technological and other factors identified in the Company’s previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward-looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
004
Press Contact
Leigh Minnier
leigh@gregoryfca.com
610-228-2108
Company Contact
Clifford Price
clifford@petlifepharma.com
844-473-8543 ext. 701
PetLife Closes Acquisition of Assets for Dr. Geoff’s Real Food for Pets
The product line is projected to include VitalZul™ in a second generation of the product in 2018
HANCOCK, MD—May 23, 2017— PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the “Company”), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, announced today that its subsidiary, Dr. Geoff’s by PetLife, Inc. (“Dr. Geoff’s by PetLife”), has completed the acquisition of assets related to the natural pet food product line.
The acquisition of the various trademarks supporting the Dr. Geoff’s Real Food for Pets™ were acquired in exchange for common stock of the Company.
The Company, through its subsidiary, will implement its plans for a national rollout to the public in the latter part of 2017. The initial flow of products includes canned food and two Superfood Supplements, ImmunoPower™ and Antioxidant Boost™, which should have many benefits for companion pets. PetLife will, over time, roll out a complete product line of 25 foods, treats, supplements, and pet accessories. These include nutraceuticals, shampoos, creams, sprays, and other natural products (i.e. supplements) for dogs and cats.
PetLife projects the inclusion of VitalZul™, the Company’s patent pending, non-toxic, bioactive formulation, into a second generation line of pet food. The active ingredients of VitalZul™ have been shown to have activity against several different cancer cell lines.
About PetLife Pharmaceuticals, Inc.
PetLife Pharmaceuticals, Inc. (PTLF) ( www.PetLifePharma.com ) is a registered U.S. Veterinary Pharmaceutical company. PetLife's mission is to bring its new, non-toxic, bioactive nutraceuticals and prescription medications to the world of veterinary oncology with the ultimate goal of preventing cancer and extending the life of pets suffering from cancer while improving their quality of life. The Company’s first product, VitalZul™, is currently in testing. VitalZul’s™ active ingredients have been shown to have activity against several different cancer cell lines. In the U.S. alone, consumer spending on domestic companion animals reached over $60 billion in 2015 with over $29 billion spent on veterinary care and medications. PetLife’s acquired brand, Dr. Geoff’s Real Food for Pets, will incorporate VitalZul™ in its pet food line in 2018.
Forward looking statement:
This press release contains certain “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. The economic, competitive, governmental, technological and other factors identified in the Company's previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward-looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Press Contact
Clifford Price
clifford@PetLifePharma.com
844-473-8543 ext. 701